Vnitr Lek 2015, 61(2):97-100

Kalcifikující uremická arteriolopatie - editorial

Sylvie Dusilová Sulková
Hemodialyzační středisko FN Hradec Králové, vedoucí lékařka prof. MUDr. Sylvie Dusilová Sulková, DrSc., MBA

Received: February 1, 2015; Published: February 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dusilová Sulková S. Kalcifikující uremická arteriolopatie - editorial. Vnitr Lek. 2015;61(2):97-100.
Download citation

References

  1. Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol 2014; 9(1): 201-218. Go to original source... Go to PubMed...
  2. Sprague SM. Painful skin ulcers in a hemodialysis patient. Clin J Am Soc Nephrol 2014; 9(1): 166-173. Go to original source... Go to PubMed...
  3. Sowers KM, Hayden MR Calcific uremic arteriolopathy. Oxidative Medicine and Cellular Longevity 2010; 3(2): 109-121. Go to original source... Go to PubMed...
  4. Sulkova S, Válek M. Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis. Nutrition 2010; 26(9): 910-914. Go to original source... Go to PubMed...
  5. Ross EA. Evolution of treatment strategies for calciphylaxis. Am J Nephrol 2011; 34(5): 460-467. Go to original source... Go to PubMed...
  6. Hanvesakul R, Silva MA, Hejmadi R et al. Calciphylaxis following kidney transplantation: a case report. J Med Case Reports 2009; 3: 92-97. Dostupné z DOI: <http://doi:10.1186/1752-1947-3-9297>. Go to original source... Go to PubMed...
  7. Bishop J, Brown E, Podesta A et al. Surgical management of calciphylaxis associated with primary hyperparathyroidism: a case report and review of the literature. Int J Endocrin 2010; pii: 823210. Dostupné z DOI: <http://doi:10.1155/2010/823210>. Go to original source... Go to PubMed...
  8. Nigwekar SU, Wolf M, Sterns RH et al. Calciphylaxis from nonuremic causes: a systemic review. Clin J Am Soc Nephrol 2008; 3(4): 1139-1143. Go to original source... Go to PubMed...
  9. Goel SK, Bellowich K, McCullough PA. Treatment of severe metastatic calcification and calciphylasis in dialysis patients. Int J Nephrol 2011; 2011:701603. Dostupné z DOI: <http://doi:10.4061/2011/701603>. Go to original source... Go to PubMed...
  10. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15(3): 172-186. Go to original source... Go to PubMed...
  11. Girotto JA, Harmon JW, Ratner LE et al. Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 2001; 130(4): 645-650. Go to original source... Go to PubMed...
  12. Duffy A, Schurr M, Warner T et al. Long-term outcomes in patients with calciphylaxis from hyperparathyroidism. Ann Surg Oncol 2006; 13(1): 96-102. Go to original source... Go to PubMed...
  13. Weenig R, Sewell LD, Davis MDP et al. Calciphylaxis: natural history, risk factor analysis and outcome. J Am Acad Dermatol 2007; 56(4): 569-579. Go to original source... Go to PubMed...
  14. Schlieper G, Brandengurg V, Ketteler M et al. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 2009; 5(9): 539-543. Go to original source... Go to PubMed...
  15. Rogers NM, Coates PT. Calcific uraemic arteriolopathy: an update. Curr Opin Nephrol Hypertens 2008; 17(6): 629-634. Go to original source... Go to PubMed...
  16. Farah M, Crawford MR, Levin A et al. Calciphylaxis in the current era: emerging "ironic" feature? Nephrol Dial Transplant 2011; 26(1): 191-195. Go to original source... Go to PubMed...
  17. Brandengurg VM, Cozzolino M, Mazzaferro S. Calcific uremic arteriolopathy: A call for action. Semin Nephrol 2014; 34(6): 641-647. Go to original source... Go to PubMed...
  18. Pujar T, Spinello EM. A 44year-old lady with chronic renal disease and intractable ulcers: a case report. Int Archives of Medicine, 2009; 2(1): 22. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.